BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 29799486)

  • 21. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of omics- and multi-omics-based techniques for natural product target discovery.
    Zhang HW; Lv C; Zhang LJ; Guo X; Shen YW; Nagle DG; Zhou YD; Liu SH; Zhang WD; Luan X
    Biomed Pharmacother; 2021 Sep; 141():111833. PubMed ID: 34175822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design.
    Friedrich L; Cingolani G; Ko YH; Iaselli M; Miciaccia M; Perrone MG; Neukirch K; Bobinger V; Merk D; Hofstetter RK; Werz O; Koeberle A; Scilimati A; Schneider G
    Adv Sci (Weinh); 2021 Aug; 8(16):e2100832. PubMed ID: 34176236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and plant-derived natural products: From ethnopharmacological approaches to their potential for modern drug discovery and development.
    Jugran AK; Rawat S; Devkota HP; Bhatt ID; Rawal RS
    Phytother Res; 2021 Jan; 35(1):223-245. PubMed ID: 32909364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncovering the therapeutic potential of natural products with biomarker-guided screening.
    Kawamura A
    IDrugs; 2010 May; 13(5):321-4. PubMed ID: 20432189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial Intelligence for Autonomous Molecular Design: A Perspective.
    Joshi RP; Kumar N
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples.
    Pirintsos S; Panagiotopoulos A; Bariotakis M; Daskalakis V; Lionis C; Sourvinos G; Karakasiliotis I; Kampa M; Castanas E
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data Resources for the Computer-Guided Discovery of Bioactive Natural Products.
    Chen Y; de Bruyn Kops C; Kirchmair J
    J Chem Inf Model; 2017 Sep; 57(9):2099-2111. PubMed ID: 28853576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of Novel Drug-like Molecules Using Informatics Rich Secondary Metabolites Analysis of Indian Medicinal and Aromatic Plants.
    Karade D; Vijayasarathi D; Kadoo N; Vyas R; Ingle PK; Karthikeyan M
    Comb Chem High Throughput Screen; 2020; 23(10):1113-1131. PubMed ID: 32504496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demystifying traditional herbal medicine with modern approach.
    Li FS; Weng JK
    Nat Plants; 2017 Jul; 3():17109. PubMed ID: 28758992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms.
    Li G; Lin P; Wang K; Gu CC; Kusari S
    Trends Cancer; 2022 Jan; 8(1):65-80. PubMed ID: 34750090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of employing computational resources for the automation of drug discovery.
    Rosales-Hernández MC; Correa-Basurto J
    Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of natural products in modern drug development.
    Dev S
    Indian J Exp Biol; 2010 Mar; 48(3):191-8. PubMed ID: 21046971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay of emerging and established technologies drives innovation in natural product antibiotic discovery.
    Bader CD; Nichols AL; Yang D; Shen B
    Curr Opin Microbiol; 2023 Oct; 75():102359. PubMed ID: 37517368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cancer glycosidase inhibitors from natural products: a computational and molecular modelling perspective.
    Singh A; Mhlongo N; Soliman ME
    Anticancer Agents Med Chem; 2015; 15(8):933-46. PubMed ID: 25706917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational techniques for lead discovery from nature.
    Rollinger JM
    Curr Pharm Des; 2010 May; 16(15):1654-5. PubMed ID: 20377521
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting Bacterial Genomes for Natural Product Discovery.
    Kalkreuter E; Pan G; Cepeda AJ; Shen B
    Trends Pharmacol Sci; 2020 Jan; 41(1):13-26. PubMed ID: 31822352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MedPServer: A database for identification of therapeutic targets and novel leads pertaining to natural products.
    Potshangbam AM; Polavarapu R; Rathore RS; Naresh D; Prabhu NP; Potshangbam N; Kumar P; Vindal V
    Chem Biol Drug Des; 2019 Apr; 93(4):438-446. PubMed ID: 30381914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic generation of chemical structures for rational drug design based on QSAR models.
    Funatsu K; Miyao T; Arakawa M
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.